Peripartum antidepressant use is associated with an increased risk of postpartum haemorrhage

Evidence-Based Medicine

Volumn 19, Issue 2, 2014, Pages 79-

  Ford, Jane B ^a   Morris, Jonathan M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; ATTRIBUTABLE RISK; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HIGH RISK PATIENT; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MOOD DISORDER; NOTE; PERINATAL PERIOD; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PREGNANT WOMAN; RISK ASSESSMENT; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; FEMALE; HUMANS; MOOD DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84897454814     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/eb-2013-101570     Document Type: Note

References (4)

1. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009;9:55.
2. Colvin L, Slack-Smith L, Stanley FJ, et al. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol 2011;91:142-52.
3. Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy. Psychol Med 2010;40:1723-33.
4. Salkeld E, Ferris LE, Juurlink DN. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 2008;28:230-4. (Pubitemid 351417131)